We provide the latest news
from the world of economics and financeAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in F5 Inc (Symbol: FFIV), where a total of 2,350 contracts have traded so far, representing approximately 235,000 underlying shares. That amounts to about 53.6% of FFIV's average daily trading volume over the past month of 438,070 shares. Particularly high volume was seen for the $300 strike call option expiring February 21, 2025, with 286 contracts trading so far today, representing approximately 28,600 underlying shares of FFIV. Below is a chart showing FFIV's trailing twelve month trading history, with the $300 strike highlighted in orange:
Eli Lilly (Symbol: LLY) saw options trading volume of 19,946 contracts, representing approximately 2.0 million underlying shares or approximately 53.4% of LLY's average daily trading volume over the past month, of 3.7 million shares. Especially high volume was seen for the $830 strike call option expiring January 31, 2025, with 1,386 contracts trading so far today, representing approximately 138,600 underlying shares of LLY. Below is a chart showing LLY's trailing twelve month trading history, with the $830 strike highlighted in orange:
And Surgery Partners Inc (Symbol: SGRY) options are showing a volume of 5,108 contracts thus far today. That number of contracts represents approximately 510,800 underlying shares, working out to a sizeable 52% of SGRY's average daily trading volume over the past month, of 982,815 shares. Especially high volume was seen for the $30 strike call option expiring September 19, 2025, with 1,096 contracts trading so far today, representing approximately 109,600 underlying shares of SGRY. Below is a chart showing SGRY's trailing twelve month trading history, with the $30 strike highlighted in orange:
For the various different available expirations for FFIV options, LLY options, or SGRY options, visit StockOptionsChannel.com.
Stock RSI
HARD Options Chain
MVC shares outstanding history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.